We are live on
!
Find out more
CGL
Clarius Group LLC Portfolio holdings
AUM
$1.75B
1-Year Est. Return
19.04%
This Fund
S&P 500
This Quarter
Est. Return
-2.06%
1 Year Est. Return
+19.04%
3 Year Est. Return
+92.07%
5 Year Est. Return
+98.79%
10 Year Est. Return
+415.93%
AUM
$1B
AUM Growth
-$1.77M
(-0.18%)
Cap. Flow
+$49.9M
Cap. Flow
% of AUM
4.99%
Top 10 Holdings %
Top 10 Hldgs %
50.06%
Holding
518
New
48
Increased
273
Reduced
136
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$21.2M |
| 2 |
State Street SPDR Portfolio Emerging Markets ETF
SPEM
|
+$8.86M |
| 3 |
Denali Therapeutics
DNLI
|
+$7.55M |
| 4 |
iShares Core MSCI International Developed Markets ETF
IDEV
|
+$3.52M |
| 5 |
Hartford Multifactor Developed Markets ex-US ETF
RODM
|
+$3.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$10.1M |
| 2 |
Invesco CurrencyShares Euro Currency Trust
FXE
|
+$3.27M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$1.46M |
| 4 |
iShares ESG Aware MSCI EM ETF
ESGE
|
+$1.25M |
| 5 |
iShares ESG Aware MSCI EAFE ETF
ESGD
|
+$899K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.4% |
| 2 | Industrials | 14.33% |
| 3 | Healthcare | 9.22% |
| 4 | Consumer Discretionary | 9.21% |
| 5 | Financials | 5.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Paycom
PAYC
$10.1B
| $205K | 0.02% |
+621
| New | +$214K |
|
452
Zebra Technologies
ZBRA
$17.2B
| $205K | 0.02% |
+783
| New | +$242K |
|
453
MGM Resorts International
MGM
$11.2B
| $204K | 0.02% |
+6,868
| New | +$223K |
|
454
RELX
RELX
$62.4B
| $204K | 0.02% |
+8,376
| New | +$227K |
|
455
Best Buy
BBY
$16.9B
| $203K | 0.02% |
+3,198
| New | +$237K |
|
456
Healthpeak Properties
DOC
$14.5B
| $202K | 0.02% |
+8,811
| New | +$233K |
|
457
Genpact
G
$6.13B
| $202K | 0.02% |
+4,612
| New | +$212K |
|
458
AES
AES
$10.5B
| $201K | 0.02% |
+8,894
| New | +$211K |
|
459
Kraft Heinz
KHC
$29.6B
| $201K | 0.02% |
6,018
+413
| +7% | +$15.3K |
|
|
IPG
460
DELISTED
Interpublic Group of Companies
IPG
| $200K | 0.02% |
+7,809
| New | +$222K |
|
461
Nasdaq
NDAQ
$52.9B
| $200K | 0.02% |
+3,536
| New | +$208K |
|
462
CAE Inc. Common Shares
CAE
$8.61B
| $198K | 0.02% |
+12,910
| New | +$276K |
|
463
Freshworks
FRSH
$3.2B
| $197K | 0.02% |
15,186
| – | – |
|
464
Mitsubishi UFJ Financial
MUFG
$254B
| $187K | 0.02% |
41,588
-8,654
| -17% | -$45.1K |
|
465
Warner Bros
WBD
$66.2B
| $159K | 0.02% |
13,831
+3,412
| +33% | +$46.4K |
|
466
ING
ING
$102B
| $151K | 0.02% |
17,741
-6,677
| -27% | -$61.9K |
|
467
Sumitomo Mitsui Financial
SMFG
$163B
| $149K | 0.01% |
27,064
-6,610
| -20% | -$39.9K |
|
468
American Airlines Group
AAL
$10.6B
| $142K | 0.01% |
+11,762
| New | +$164K |
|
469
BlackBerry
BB
$5.15B
| $136K | 0.01% |
29,024
-7,580
| -21% | -$45.3K |
|
|
SYRS
470
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $125K | 0.01% |
19,347
-1
| -0% | -$8 |
|
|
ACCD
471
DELISTED
Accolade Inc
ACCD
| $121K | 0.01% |
10,585
| – | – |
|
472
Lyell Immunopharma
LYEL
$348M
| $120K | 0.01% |
820
| – | – |
|
473
Vodafone
VOD
$37B
| $115K | 0.01% |
+10,189
| New | +$142K |
|
|
ORAN
474
DELISTED
Orange
ORAN
| $112K | 0.01% |
+12,497
| New | +$128K |
|
475
Pearson
PSO
$9.97B
| $111K | 0.01% |
11,572
-3,402
| -23% | -$33.9K |
|
Similar funds
A
CB
JCM
GH
MPM
NAS
RC
LGWM
Clarius Group LLC's Q3 2022 Portfolio in Review
As of Q3 2022, Clarius Group LLC held 518 positions worth $1B, down 0.18% from $1B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Clarius Group LLC deployed $49.9M of net new capital in Q3 2022, opening 48 new positions and adding to 273 existing holdings. Its largest new stake was Vanguard Total World Stock ETF: 16,020 shares worth $1.26M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was iShares Core MSCI Emerging Markets ETF, an estimated $10.1M trimmed.
- Clarius Group LLC's largest Q3 2022 buy was Vanguard Total World Stock ETF: 16,020 shares worth $1.26M.
- Clarius Group LLC added most to Karuna Therapeutics, Inc. Common Stock in Q3 2022, an estimated $21.2M increase.
- Clarius Group LLC's biggest Q3 2022 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $10.1M.
- Clarius Group LLC fully exited Invesco CurrencyShares Euro Currency Trust in Q3 2022, selling an estimated $3.27M.
- Clarius Group LLC's ten largest holdings make up 50% of its $1B portfolio in Q3 2022.
- Clarius Group LLC opened 48 new positions and closed 24 in Q3 2022.
- Clarius Group LLC's portfolio value fell 0.18% quarter-over-quarter to $1B.
Based on Clarius Group LLC's 13F filing for Q3 2022, filed 24 Oct 2022.